Mitral Valve Mass Detected on Preoperative Transesophageal Echocardiogram

2013 ◽  
Vol 27 (5) ◽  
pp. 1070-1072
Author(s):  
Himani Bhatt ◽  
Muoi Trinh ◽  
Gregory W. Fischer
Keyword(s):  
Mitral Valve ◽  
Transesophageal Echocardiogram

scholarly journals Giant Left Atrial Myxoma Presenting with Cough-Syncope Syndrome

2021 ◽  
Vol 24 (4) ◽  
pp. E7090-E712
Author(s):  
Esra Ertürk tekin
Keyword(s):  
Mitral Valve ◽  
Left Ventricle ◽  
Left Atrium ◽  
Left Atrial ◽  
Interatrial Septum ◽  
Atrial Myxoma ◽  
Transesophageal Echocardiogram ◽  
Left Atrial Myxoma ◽  
Cardiac Surgeon ◽  
The Mean

We report the case of a 41-year-old female patient with symptoms of cerebrovascular accident manifesting with loss of consciousness during episodes of cough. Computed multislice chest tomography showed a 7.3- by 4.15-cm mass in the left atrium. A transesophageal echocardiogram showed a giant mass in the left atrium that passed through the mitral valve to the left ventricle, and severe obstructive stenosis was suggested by the mean transmitral gradient. After a comprehensive assessment of the mass, we decided to perform surgery. The pedunculated and fragile mass was attached to the interatrial septum with its handle, and the majority of it prolapsed through the mitral valve to the left ventricle and became stacked among the mitral valve leaflets. The removed mass was analyzed histopathologically and was found to be a myxoma. It is important for the cardiac surgeon to surgically remove an atrial myxoma because of the risks associated with embolization, including sudden death, as myxoma can block the blood supply from the atrium to the ventricle.

scholarly journals Septic pulmonary emboli from mitral valve endocarditis in a patient with repaired tetralogy of fallot

2016 ◽  
Vol 3 (3) ◽  
pp. 7
Author(s):  
Aniket S. Rali ◽  
Arun Iyer ◽  
Claire Sullivan ◽  
James Strainic ◽  
Brian Hoit
Keyword(s):  
Mitral Valve ◽  
Septal Defect ◽  
Pulmonary Emboli ◽  
Transesophageal Echocardiogram ◽  
Bronchial Arteries ◽  
Lower Extremity Weakness ◽  
Septic Emboli ◽  
Multiple Organs ◽  
Computed Tomography Images ◽  
History Of

A 37-year-old woman with a past medical history significant for congenital deafness and surgically repaired Tetralogy ofFallot presented with three day history of nausea, vomiting, fever, chills, dyspnea, and lower extremity weakness and physicalexamination notable for Janeway lesions. Peripheral blood and urine cultures were positive for methicillin sensitive Staphlococcusaureus. Transesophageal echocardiogram was consistent with mitral valve endocarditis. Computed tomography images of thechest, abdomen and pelvis demonstrated septic emboli to multiple organs including lungs, liver, spleen and kidneys. Salinecontrast study was negative for a patent foramen ovale, or residual ventricular septal defect. Thus, effectively ruling out left toright intracardiac shunt as the cause of pulmonary septic emboli from mitral valve endocarditis. Moreover, cardiac MRI did notshow any evidence of right sided endocarditis. Therefore, we believe the source of septic pulmonary emboli from mitral valveendocarditis to be through the bronchial arteries. The extent of septic emboli to various organs and the precise mechanism ofpulmonary emboli from left sided endocarditis in a patient with surgically altered cardiac anatomy make this case unique.

scholarly journals Mitral Valve Annuloplasty Ring Dehiscence Diagnosed Intraoperative With Real-Time 3D Transesophageal Echocardiogram

2014 ◽  
Vol 2 (2) ◽  
pp. 232470961453882 ◽  
Author(s):  
Karina Castellon-Larios ◽  
Alix Zuleta-Alarcon ◽  
Antolin Flores ◽  
Michelle Humeidan ◽  
Andrew N. Springer ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Real Time ◽  
Transesophageal Echocardiogram ◽  
Annuloplasty Ring ◽  
Mitral Valve Annuloplasty

Transcatheter Mitral Valve Implantation: 30-day Outcome of First-in-Man Experience with an Apically Tethered Device

2016 ◽  
Vol 11 (3) ◽  
pp. 174-178 ◽  
Author(s):  
Cesare Quarto ◽  
Simon Davies ◽  
Alison Duncan ◽  
Alistair Lindsay ◽  
Georg Lutter ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Left Ventricular Outflow Tract ◽  
Ventricular Outflow Tract ◽  
Left Ventricular ◽  
Outflow Tract ◽  
Heart Team ◽  
Bypass Grafts ◽  
Transesophageal Echocardiogram ◽  
Ventricular Outflow Tract Obstruction ◽  
Left Ventricular Outflow

Objective A small number of transcatheter mitral valve implants (TMVIs) have been reported using devices designed to treat secondary mitral regurgitation (MR). However, MR has many etiologies, and patients have a broad spectrum of annular size, geometry, and lesions. There are a number of technical challenges for TMVI including left ventricular outflow tract obstruction and paravalvular MR. Thirty days’ outcome of first-in-man implants with a novel TMVI device is reported. Methods The Tendyne TMVI system consists of a porcine pericardial valve in a tethered nitinol frame. An apical tether fixed to an epicardial pad stabilizes the device. The device is fully repositionable and retrievable even after complete deployment. Preoperative assessment was performed with 3-dimensional (3D) transesophageal echocardiogram and multislice computed tomography to define annular dimensions, geometry, and guide surgical access. Three patients were deemed not to be candidates for conventional surgery or for treatment with any Conformitè Européenne-marked device by Heart Team Evaluation. They were a 68-year-old woman with prior coronary artery bypass grafts and severe functional MR; a 75-year-old man with prior coronary bypass grafts, significant renal dysfunction, and severe degenerative MR; and a frail 86-year-old man with severe degenerative MR. Each had a TMVI via a transapical approach through a left minithoracotomy. Apical tether tension was adjusted to optimize device position. Results Implantation was guided by 2D and 3D transesophageal echocardiogram. The apical pad facilitated LV apical closure. There were no procedural complications. No patient had hemodynamically significant residual MR or left ventricular outflow tract obstruction, and there was no significant mitral gradient. All patients were discharged to their own home (the third on the fifth postoperative day), all with significant improvement in their symptoms. All were alive and well 30 days after implant. Two patients with existing conduction abnormalities had cardiac resynchronisation therapy after the procedure, and one patient had para valvular leak (PVL) with evidence of hemolysis at 30 days, which reduced in severity with conservative treatment. Conclusions The first-in-man experience with the Tendyne TMVI system is promising. Valve stabilization by an apical tether is a novel way to address some of the challenges of TMVI. The unique Tendyne design features may offer potential for its use across a wide range of mitral valve pathologies.

Sign in / Sign up

Export Citation Format

Share Document